Table of Content

1. Executive Summary
1.1. Global Sleep Aids Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025 – 2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overviews
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors – Relevance and Impact
3. Value Added Insights
3.1. Drug Adoption Analysis
3.2. Value Chain Analysis
3.2.1. List of End-user/Marketplaces
3.2.1.1. Retail
3.2.1.2. E-commerce
3.2.2. List of Indication (Industry)
3.3. Key Deals and Mergers
3.4. PESTLE Analysis
3.5. Porter’s Five Force Analysis
4. Global Sleep Aids Market Outlook
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025–2032
4.3. Global Sleep Aids Market Outlook: Product Type
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 – 2023
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
4.3.3.1. Drugs
4.3.3.1.1. Doxepin Hydrochloride
4.3.3.1.2. Eszopiclone
4.3.3.1.3. Ramelteon
4.3.3.1.4. Triazolam
4.3.3.1.5. Zaleplon
4.3.3.1.6. Quazepam
4.3.3.1.7. Others
4.3.3.2. Narcolepsy Treatment Drugs
4.3.3.2.1. Modafinil
4.3.3.2.2. Sodium Oxybate
4.3.3.2.3. Armodafinil
4.3.3.2.4. Others
4.3.3.3. Devices
4.3.3.3.1. CPAP Devices
4.3.3.3.2. BiPAP Devices
4.3.3.3.3. APAP Devices
4.3.4. Market Attractiveness Analysis: Product Type
4.4. Global Sleep Aids Market Outlook: Indication
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019 – 2023
4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 – 2032
4.4.3.1. Insomnia
4.4.3.2. Sleep Deprivation
4.4.3.3. Narcolepsy
4.4.3.4. Sleep Apnea
4.4.3.5. Others
4.4.4. Market Attractiveness Analysis: Indication
4.5. Global Sleep Aids Market Outlook: Distribution Channel
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019 – 2023
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
4.5.3.1. Hospital Pharmacies
4.5.3.2. Retail Pharmacies
4.5.3.3. E-commerce
4.5.3.4. Drug Stores
4.5.3.5. Others
4.5.4. Market Attractiveness Analysis: Distribution Channel
5. Global Sleep Aids Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 – 2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025 – 2032
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Sleep Aids Market Outlook
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
6.2.1. By Country
6.2.2. By Product Type
6.2.3. By Indication
6.2.4. By Distribution Channel
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
6.4.1. Drugs
6.4.1.1. Doxepin Hydrochloride
6.4.1.2. Eszopiclone
6.4.1.3. Ramelteon
6.4.1.4. Triazolam
6.4.1.5. Zaleplon
6.4.1.6. Quazepam
6.4.1.7. Others
6.4.2. Narcolepsy Treatment Drugs
6.4.2.1. Modafinil
6.4.2.2. Sodium Oxybate
6.4.2.3. Armodafinil
6.4.2.4. Others
6.4.3. Devices
6.4.3.1. CPAP Devices
6.4.3.2. BiPAP Devices
6.4.3.3. APAP Devices
6.5. Market Attractiveness Analysis
7. Europe Sleep Aids Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
7.2.1. By Country
7.2.2. By Product Type
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
7.4.1. Drugs
7.4.1.1. Doxepin Hydrochloride
7.4.1.2. Eszopiclone
7.4.1.3. Ramelteon
7.4.1.4. Triazolam
7.4.1.5. Zaleplon
7.4.1.6. Quazepam
7.4.1.7. Others
7.4.2. Narcolepsy Treatment Drugs
7.4.2.1. Modafinil
7.4.2.2. Sodium Oxybate
7.4.2.3. Armodafinil
7.4.2.4. Others
7.4.3. Devices
7.4.3.1. CPAP Devices
7.4.3.2. BiPAP Devices
7.4.3.3. APAP Devices
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 – 2032
7.5.1. Insomnia
7.5.2. Sleep Deprivation
7.5.3. Narcolepsy
7.5.4. Sleep Apnea
7.5.5. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
7.6.1. Hospital Pharmacies
7.6.2. Retail Pharmacies
7.6.3. E-commerce
7.6.4. Drug Stores
7.6.5. Others
7.7. Market Attractiveness Analysis
8. East Asia Sleep Aids Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
8.2.1. By Country
8.2.2. By Product Type
8.2.3. By Indication
8.2.4. By Distribution Channel
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
8.4.1. Drugs
8.4.1.1. Doxepin Hydrochloride
8.4.1.2. Eszopiclone
8.4.1.3. Ramelteon
8.4.1.4. Triazolam
8.4.1.5. Zaleplon
8.4.1.6. Quazepam
8.4.1.7. Others
8.4.2. Narcolepsy Treatment Drugs
8.4.2.1. Modafinil
8.4.2.2. Sodium Oxybate
8.4.2.3. Armodafinil
8.4.2.4. Others
8.4.3. Devices
8.4.3.1. CPAP Devices
8.4.3.2. BiPAP Devices
8.4.3.3. APAP Devices
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 – 2032
8.5.1. Insomnia
8.5.2. Sleep Deprivation
8.5.3. Narcolepsy
8.5.4. Sleep Apnea
8.5.5. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
8.6.1. Hospital Pharmacies
8.6.2. Retail Pharmacies
8.6.3. E-commerce
8.6.4. Drug Stores
8.6.5. Others
8.7. Market Attractiveness Analysis
9. South Asia and Oceania Sleep Aids Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
9.2.1. By Country
9.2.2. By Product Type
9.2.3. By Indication
9.2.4. By Distribution Channel
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
9.4.1. Drugs
9.4.1.1. Doxepin Hydrochloride
9.4.1.2. Eszopiclone
9.4.1.3. Ramelteon
9.4.1.4. Triazolam
9.4.1.5. Zaleplon
9.4.1.6. Quazepam
9.4.1.7. Others
9.4.2. Narcolepsy Treatment Drugs
9.4.2.1. Modafinil
9.4.2.2. Sodium Oxybate
9.4.2.3. Armodafinil
9.4.2.4. Others
9.4.3. Devices
9.4.3.1. CPAP Devices
9.4.3.2. BiPAP Devices
9.4.3.3. APAP Devices
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 – 2032
9.5.1. Insomnia
9.5.2. Sleep Deprivation
9.5.3. Narcolepsy
9.5.4. Sleep Apnea
9.5.5. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
9.6.1. Hospital Pharmacies
9.6.2. Retail Pharmacies
9.6.3. E-commerce
9.6.4. Drug Stores
9.6.5. Others
9.7. Market Attractiveness Analysis
10. Latin America Sleep Aids Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
10.2.1. By Country
10.2.2. By Product Type
10.2.3. By Indication
10.2.4. By Distribution Channel
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
10.4.1. Drugs
10.4.1.1. Doxepin Hydrochloride
10.4.1.2. Eszopiclone
10.4.1.3. Ramelteon
10.4.1.4. Triazolam
10.4.1.5. Zaleplon
10.4.1.6. Quazepam
10.4.1.7. Others
10.4.2. Narcolepsy Treatment Drugs
10.4.2.1. Modafinil
10.4.2.2. Sodium Oxybate
10.4.2.3. Armodafinil
10.4.2.4. Others
10.4.3. Devices
10.4.3.1. CPAP Devices
10.4.3.2. BiPAP Devices
10.4.3.3. APAP Devices
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 – 2032
10.5.1. Insomnia
10.5.2. Sleep Deprivation
10.5.3. Narcolepsy
10.5.4. Sleep Apnea
10.5.5. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
10.6.1. Hospital Pharmacies
10.6.2. Retail Pharmacies
10.6.3. E-commerce
10.6.4. Drug Stores
10.6.5. Others
10.7. Market Attractiveness Analysis
11. Middle East & Africa Sleep Aids Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
11.2.1. By Country
11.2.2. By Product Type
11.2.3. By Indication
11.2.4. By Distribution Channel
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
11.4.1. Drugs
11.4.1.1. Doxepin Hydrochloride
11.4.1.2. Eszopiclone
11.4.1.3. Ramelteon
11.4.1.4. Triazolam
11.4.1.5. Zaleplon
11.4.1.6. Quazepam
11.4.1.7. Others
11.4.2. Narcolepsy Treatment Drugs
11.4.2.1. Modafinil
11.4.2.2. Sodium Oxybate
11.4.2.3. Armodafinil
11.4.2.4. Others
11.4.3. Devices
11.4.3.1. CPAP Devices
11.4.3.2. BiPAP Devices
11.4.3.3. APAP Devices
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 – 2032
11.5.1. Insomnia
11.5.2. Sleep Deprivation
11.5.3. Narcolepsy
11.5.4. Sleep Apnea
11.5.5. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
11.6.1. Hospital Pharmacies
11.6.2. Retail Pharmacies
11.6.3. E-commerce
11.6.4. Drug Stores
11.6.5. Others
11.7. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2025
12.2. Market Structure
12.2.1. Competition Intensity Mapping by Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
12.3.1. ResMed Inc.
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Koninklijke Philips N.V.
12.3.3. Merck & Co. Inc.
12.3.4. Drive DeVilbiss Healthcare LLC
12.3.5. GlaxoSmithKline Plc.
12.3.6. Fisher & Paykel Healthcare Limited
12.3.7. Sanofi SA
12.3.8. Pfizer Inc.
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations